Skip to main content
SpringerLink
Log in

Generalised Dermatitis Induced by Pegylated Interferon-α-2b in a Patient Infected with Genotype-1 Hepatitis C Virus

Presentation of a Case

  • Case Report
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Poynard T, Leroy V, Mathurin P, et al. Treatment of chronic hepatitis C by interferon for longer duration than six months. Dig Dis sci 1996 Dec; 41(12 Suppl.): 99S–102S

    Article  PubMed  CAS  Google Scholar 

  2. Carithers Jr RL, Emerson SS. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology 1997; 26(3 Suppl.): 83S–8S

    Article  PubMed  CAS  Google Scholar 

  3. Farrell GC. Therapy of hepatitis C: interferon alfa-n1 trials. Hepatology 1997; 26 (3 Suppl. 1): 96S–100S

    Article  PubMed  CAS  Google Scholar 

  4. Wang YS, Youngster S, Grace M, et al. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv Drug Deliv Rev 2002; 54: 547–70

    Article  PubMed  CAS  Google Scholar 

  5. Shiffman ML. Pegylated interferons: what role will they play in the treatment of chronic hepatitis C? Curr Gastroenterol Rep 2001 Feb; 3(1): 30–7

    Article  PubMed  CAS  Google Scholar 

  6. Poynard T. Effect of pegylated interferon on liver histology. Drug Saf 2002; 2: 14–5

    Google Scholar 

  7. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958–6

    Article  PubMed  CAS  Google Scholar 

  8. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975–82

    Article  PubMed  CAS  Google Scholar 

  9. Cnudde F, Gharakhanian S, Luboinski J, et al. Cutaneous local necrosis following interferon injections [letter]. Int J Dermatol 1991; 30: 147

    Article  PubMed  CAS  Google Scholar 

  10. Gallelli L, Guadagnino V, Caroleo B, et al. Cutaneous ulceration induced by interferon alfa. Ann Pharmacother 2004; 38: 173–14

    PubMed  Google Scholar 

  11. Poynard T, Marcellin P, Lee SS, et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426–32

    Article  PubMed  CAS  Google Scholar 

  12. McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485–92

    Article  PubMed  CAS  Google Scholar 

  13. Sookoian S, Neglia V, Castano G, et al. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000–1

    Article  PubMed  CAS  Google Scholar 

  14. Hadziyannis SJ. Skin diseases associated with hepatitis C virus infection. J Eur Acad Dermatol Venereol 1998; 10: 12–21

    Article  PubMed  CAS  Google Scholar 

  15. Romero M, Perez-Olmeda M, Garcia-Samaniego J, et al. Management of chronic hepatitis C in patients co-infected with HIV: focus on safety considerations. Drug Saf 2004; 27(1): 7–24

    Article  PubMed  CAS  Google Scholar 

  16. Lambert J, Jonlet F, Vanhooteghem O, et al. A non-infectious pyodermatitis: pyoderma gangrenosum. Rev Med Liege 2001; 56: 106–11

    PubMed  CAS  Google Scholar 

  17. Guarneri C, Vaccaro M, Cannavo SP, et al. Erythematous-edematous-infiltrative plaque on the face: cutaneous angiolupoid leishmaniasis. Eur J Dermatol 2002; 12: 597–9

    PubMed  Google Scholar 

  18. Noblesse I, Beylot-Barry M, Doutre MS, et al. Cutaneous manifestations of rickettsiosis. Ann Dermatol Venereol 2002; 129: 1199–203

    PubMed  CAS  Google Scholar 

  19. Maddrey WC. Safety of combination interferon alfa-2b/ ribavirin therapy in chronic hepatitis C-relapsed and treatmentnaive patients. Semin Liver Dis 1999; 19Suppl. 1: 67–75

    PubMed  CAS  Google Scholar 

  20. Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004 Feb; 140(2): 215–7

    Article  PubMed  Google Scholar 

  21. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 Aug; 30(2): 239–45

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by the Ministero della Salute (Programma di Ricerca Finalizzata anno 2002: “Farmaci e fitoterapici, impatto sulla salute, vigilanza e sviluppo di un modello organizzativo interregionale”. Programmi Speciali ex Art. 12, D.Lgs 502/99 e successive modificazioni e integrazioni). The authors have no conflicts of interest directly relevant to the content of this study.

Author information

Authors and Affiliations

  1. Clinical Pharmacology and Pharmacovigilance Unit, Department of Experimental and Clinical Medicine, Faculty of Medicine and Surgery, University ‘Magna Graecia’ of Catanzaro, Via T. Campanella 115, 88100, Catanzaro, Italy

    L. Gallelli & G. De Sarro

  2. Internal Medicine Operative Unit, San Giovanni in Fiore Hospital, San Giovanni in Fiore, Cosenza, Italy

    M. Ferraro & G. F. Mauro

Authors
  1. L. Gallelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Ferraro
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. F. Mauro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. De Sarro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Gallelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gallelli, L., Ferraro, M., Mauro, G.F. et al. Generalised Dermatitis Induced by Pegylated Interferon-α-2b in a Patient Infected with Genotype-1 Hepatitis C Virus. Clin. Drug Investig. 25, 281–284 (2005). https://doi.org/10.2165/00044011-200525040-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200525040-00009

Keywords

Search

Navigation